Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 106.00
Bid: 105.00
Ask: 106.00
Change: 0.50 (0.47%)
Spread: 1.00 (0.952%)
Open: 105.00
High: 106.00
Low: 103.50
Prev. Close: 105.50
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

11 Jun 2020 07:00

RNS Number : 6026P
McBride PLC
11 June 2020
 

11 June 2020

 

McBride plc

 

Directorate Change

 

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, announces the appointment of Chris Smith as Chief Executive Officer (CEO) from today. Chris joined the Group in 2015 as Chief Financial Officer (CFO).

 

Ludwig de Mot, who was appointed CEO on 1 November 2019, has left the Group with immediate effect. We are grateful for his contribution to McBride and wish him well in his future endeavours.

 

The Group's Nomination Committee has commenced a search for a CFO and in the meantime the Group intends to appoint an external candidate as interim who will be supported by the Group's experienced finance team. During this time, Chris will provide support with the transition and an orderly handover of CFO responsibilities to his successor.

 

The Board can confirm that there has been no material change in the trading or financial prospects of the Group since McBride issued its trading update on 19 May 2020.

 

Jeff Nodland, Chairman, said:

 

"I am delighted that Chris has accepted the role as the Group's new CEO. Over the five years Chris has been with McBride, he has demonstrated his strong international leadership capabilities in multi-site and multi-country organisations. Chris has always been dedicated and passionate about the business and the Board believe his determination and enthusiasm make him the best person to lead the Company through its strategy review and beyond."

 

Chris Smith said:

 

"I look forward to working with the Board and the wider team at McBride as CEO to complete our strategy review and take the business forward as we implement our plans. I firmly believe in our ability to create sustained value for our shareholders as we continue to evolve and adapt this business for the future."

 

For further information please contact:

 

McBride plc

Chris Smith, Chief Executive Officer

0161 203 7570

Glenda MacGeekie, Company Secretary

FTI Consulting LLP

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

 

-Ends-

 

 

Notes and other disclosures

 

Payments on termination to Mr de Mot will be made in accordance with his service contract. No bonus or share awards are due under the Remuneration Policy or otherwise.

 

 

There are no additional matters that would require disclosure under LR 9.6.11 or LR 9.6.14.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAFKEFELEEAA
Date   Source Headline
30th Aug 20224:35 pmRNSPrice Monitoring Extension
25th Aug 20226:22 pmRNSCorrection - Result of General Meeting
25th Aug 20224:40 pmRNSResult of AGM
22nd Aug 20223:41 pmRNSHolding(s) in Company
15th Aug 20225:48 pmRNSHolding(s) in Company
9th Aug 20227:00 amRNSNotice of General Meeting
14th Jul 20227:00 amRNSFull year trading update
29th Jun 20227:00 amRNSJune 2022 - Bank Covenant Waiver
17th Jun 20224:42 pmRNSSecond Price Monitoring Extn
17th Jun 20224:36 pmRNSPrice Monitoring Extension
9th Jun 20221:55 pmRNSDirector/PDMR Shareholding
24th May 20223:20 pmRNSDirector/PDMR Shareholding
23rd May 202212:31 pmRNSDirector/PDMR Shareholding
13th May 20227:00 amRNSDirector/PDMR Shareholding
25th Apr 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20221:19 pmRNSDirector/PDMR Shareholding
18th Mar 202210:05 amRNSDirector/PDMR Shareholding
7th Mar 202210:03 amRNSDirector/PDMR Shareholding
28th Feb 20225:47 pmRNSDirector/PDMR Shareholding
24th Feb 20225:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20227:00 amRNSHalf-year Report
18th Feb 20227:00 amRNSBoard Changes
22nd Dec 20213:02 pmRNSDecember 2021 - Bank Covenant Waiver
16th Dec 20217:00 amRNSFinancial Year 2022 Trading Update
26th Nov 20219:48 amRNSDirector/PDMR Shareholding
26th Nov 20217:00 amRNSRedemption of B Shares
8th Nov 20212:02 pmRNSDirector/PDMR Shareholding
26th Oct 20213:01 pmRNSDirector/PDMR Shareholding
26th Oct 20212:21 pmRNSDirector/PDMR Shareholding
26th Oct 20211:35 pmRNSDirector/PDMR Shareholding
19th Oct 20216:05 pmRNSResult of AGM
19th Oct 20217:00 amRNSAGM Trading Update
7th Oct 20213:05 pmRNSDirector/PDMR Shareholding
5th Oct 20216:21 pmRNSCorrection to the Annual Report
30th Sep 20216:16 pmRNSRedemption of B Shares
24th Sep 20217:00 amRNSAnnual Report 2021 and Annual General Meeting 2021
13th Sep 20213:27 pmRNSDirector/PDMR Shareholding
7th Sep 20214:05 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSFinal Results
2nd Sep 20215:00 pmRNSTransaction in Own Shares
1st Sep 20215:29 pmRNSTransaction in Own Shares
31st Aug 20215:14 pmRNSTransaction in Own Shares
25th Aug 20215:18 pmRNSTransaction in Own Shares
24th Aug 20215:09 pmRNSTransaction in Own Shares
23rd Aug 20215:33 pmRNSTransaction in Own Shares
20th Aug 20215:00 pmRNSTransaction in Own Shares
19th Aug 20215:49 pmRNSTransaction in Own Shares
19th Aug 20217:00 amRNSFinancial Year 2022 trading update
14th Jul 20217:00 amRNSFull year trading update
9th Jul 20211:27 pmRNSReplacement: Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.